These findings reinforce the view that obesity is a chronic, relapsing condition, and that ongoing treatment may be necessary to sustain the health benefits achieved with incretin-based therapies
Absolute risk remains very small 462 per million vs 238 per million
Cancer 19 (5), F77F88
Unfortunately, I think insurance will still primarily determine how people choose which medication to take for weight loss, Dushay says
It plays several important roles in how your body manages energy: It signals your pancreas to release insulin when blood sugar rises It slows the rate at which food leaves your stomach, making you feel full longer It acts on the brains hunger centers to reduce appetite and food cravings It lowers glucagon, a hormone that triggers the liver to release stored sugar GLP-1 receptor agonists are medications that mimic and amplify these effects
Carolynn Francavilla, vice president of the Obesity Medicine Association, says programs like Vida's can be helpful for some obesity-drug patients who like using telehealth apps for logging food and getting other support